CYCLOTRONS 2010 - List of Keywords (isotope-production)

Paper	Title	Other Keywords	Page
MOPCP011	25 Years of Continuous Operation of the Seattle Clinical Cyclotron Facility	controls, cyclotron, target, radiation	66
	R. Risler, S.P. Banerian, J.G. Douglas, R.C. Emery, I.J. Kalet, G.E. Laramore, D.D. Reid University of Washington Medical Center, Seattle, USA
	The clinical cyclotron facility at the University of Washington Medical Center has now been in continuous operation for over 25 years. It is highly reliable, and its primary use is still for fast neutron therapy, mostly for salivary gland tumors. Neutron therapy accounts for about 85% of the facility use time. In cases where the tumor involves the base of the skull, significant improvements of patient outcome have been achieved by combining the neutron treatment with a gamma knife boost to areas where the neutron dose is limited by adjacent healthy tissue. Production of 211-At and 117m-Sn with alpha particles at 29.0 and 47.3 MeV and currents between 50 and 70 μA have become routine. These isotopes are used in medical applications presently under development. The introduction of a new control system using EPICS (Experimental Physics and Industrial Control System) is progressing systematically. All the user interfaces are up and running, and several accelerator subsystems have been migrated to the new controls. No interruption of therapy or isotope production operation is planned for the conversion to the new control system.

MOPCP037	Central Region Design of a Baby Cyclotron	cyclotron, ion, ion-source, extraction	126
	X. He TUB, Beijing, People's Republic of China K. Zhang CAEP/IFP, Mainyang, Sichuan, People's Republic of China
	Baby cyclotrons are widely used in short lived beta+ radioactive isotope production for PET. Central region design is one of the most important part of the design work of the cyclotron. Central region design, including design process and design results is presentd in this paper.

Paper

Title

Other Keywords

Page

MOPCP011

25 Years of Continuous Operation of the Seattle Clinical Cyclotron Facility

controls, cyclotron, target, radiation

66

R. Risler, S.P. Banerian, J.G. Douglas, R.C. Emery, I.J. Kalet, G.E. Laramore, D.D. Reid
University of Washington Medical Center, Seattle, USA

The clinical cyclotron facility at the University of Washington Medical Center has now been in continuous operation for over 25 years. It is highly reliable, and its primary use is still for fast neutron therapy, mostly for salivary gland tumors. Neutron therapy accounts for about 85% of the facility use time. In cases where the tumor involves the base of the skull, significant improvements of patient outcome have been achieved by combining the neutron treatment with a gamma knife boost to areas where the neutron dose is limited by adjacent healthy tissue. Production of 211-At and 117m-Sn with alpha particles at 29.0 and 47.3 MeV and currents between 50 and 70 μA have become routine. These isotopes are used in medical applications presently under development. The introduction of a new control system using EPICS (Experimental Physics and Industrial Control System) is progressing systematically. All the user interfaces are up and running, and several accelerator subsystems have been migrated to the new controls. No interruption of therapy or isotope production operation is planned for the conversion to the new control system.

MOPCP037

Central Region Design of a Baby Cyclotron

cyclotron, ion, ion-source, extraction

126

X. He
TUB, Beijing, People's Republic of China
K. Zhang
CAEP/IFP, Mainyang, Sichuan, People's Republic of China

Baby cyclotrons are widely used in short lived beta+ radioactive isotope production for PET. Central region design is one of the most important part of the design work of the cyclotron. Central region design, including design process and design results is presentd in this paper.